Carl Hansen
CanadaexecutiveMale7.5Global Dominance: 0.00%Carl Hansen is the Chief Executive Officer of AbCellera Biologics Inc., a Canada-based biotech company. He has voiced concerns that significant reductions in U.S. drug spending, as proposed by recent executive orders, could devastate the pharmaceutical industry unless other countries compensate for the loss. Hansen emphasizes the importance of high prices for successful drug development to account for the costs associated with bringing new medications to market.
Country presence
Recent news mentions
Carl Hansen is the CEO of AbCellera.
AbCellera stock soars on ‘off the chart’ trial results from hot flash treatment for menopausal womenCanada· 2026-08-10
Carl Hansen is the CEO of AbCellera, aiming to build it into Canada's first homegrown Big Pharma giant.
Has Canada’s biotech moment finally arrived?Canada· 2026-08-04
Carl Hansen, vice president and head of government relations at Coco Robotics, commented on the incident involving the robot.
Train strikes food delivery robot stuck on railroad tracks in Miami
United States· 2026-01-19
Carl Hansen is the chief executive of AbCellera.
Defence spending must include health spending tooCanada· 2025-09-02
Carl Hansen, CEO of Canada-based biotech company AbCellera Biologics Inc., said a dramatic drop in how much the U.S. spends on drugs could be devastating to the pharmaceutical industry.
Trump says new order will lower U.S. drug prices and increase them everywhere elseCanada· 2025-05-13
